hATTR Amyloidosis: A Rare Condition Disproportionately Affecting African Americans


In partnership with The Balm in Gilead, the goal of this webinar is to provide education about hereditary ATTR (hATTR) amyloidosis, a rare condition disproportionately affecting African Americans.

Join us to hear from Dr. Ike Okwuosa, a healthcare professional experienced in the management of hATTR amyloidosis, and Jean, a patient living with this rare, genetic disease. Approximately 1 in 25 (4%) of African Americans have a certain genetic variant associated with hATTR amyloidosis. Learn how to recognize the signs and symptoms of the disease, how it’s passed down, and where to find additional educational resources.

There is no cost to attend this virtual event.

I agree to the Alnylam Privacy Policy below.


May 10, 2022 06:30 PM in Eastern Time (US and Canada)

Webinar Registration

*Required information

To learn more about hATTR amyloidosis, visit
This event is sponsored by Alnylam Pharmaceuticals. By registering, I agree to the Alnylam, Privacy Policy. I am 18 years or older, a US resident, and consent to the processing of my personal data per the terms outlined in the Data Privacy Notification and Consent.

The Bridge and its associated logo are trademarks of Alnylam Pharmaceuticals, Inc.

© 2022 Alnylam Pharmaceuticals, Inc. All rights reserved. NP-USA-00341-V2


Ike Okwuosa, MD

Advanced Heart Failure & Transplant Cardiologist at Northwestern Medicine

Valerie Graham

Alnylam Patient Education Liaison at Alnylam Pharmaceuticals, Inc.

Jean, living with hATTR amyloidosis

Patient Ambassador